Post-Prostatectomy Incontinence: Surgical Versus Conservative Management
A 65-year-old man undergoes robot-assisted radical prostatectomy for Gleason 3+4 prostate cancer. Six months postoperatively, he complains of urinary incontinence, using 3 pads per day. He has tried pelvic floor muscle exercises with a physical therapist for 3 months without significant improvement. His cystoscopy shows a normal anastomosis without stricture, and urodynamics demonstrate stress urinary incontinence with a Valsalva leak point pressure of 60 cm H2O and no detrusor overactivity. His prostate-specific antigen is undetectable. He is motivated to avoid further surgery if possible but wants to be dry. The urologist must discuss options.
1. What are the treatment options for post-prostatectomy incontinence, and what is the role of urodynamics in this case?
Read the worked answer
Treatment options: 1) Conservative: continued pelvic floor muscle training, biofeedback, lifestyle modifications (fluid management, caffeine reduction), and penile clamp or external collection devices. 2) Medications: duloxetine has modest evidence but is not FDA approved for this indication. 3) Minimally invasive: male sling (e.g., AdVance, Virtue) for mild to moderate incontinence; artificial urinary sphincter (AUS) for moderate to severe incontinence. 4) Injectable bulking agents: limited efficacy. Urodynamics role: Confirms the diagnosis of stress urinary incontinence, rules out detrusor overactivity, and assesses sphincter function (Valsalva leak point pressure). In this patient, VLPP of 60 cm H2O indicates sphincter deficiency (intrinsic sphincter deficiency is typically <60-100 cm H2O). The absence of detrusor overactivity is important. Urodynamics help guide treatment: AUS is the gold standard for moderate to severe stress incontinence, especially with low VLPP. Male sling is an option for mild incontinence (1-3 pads) but may be less effective with low VLPP. Given he uses 3 pads/day and failed conservative therapy, AUS is the most durable option. However, patient preference and expectations should be discussed.
2. How would you counsel the patient regarding the choice between artificial urinary sphincter and male sling, including risks and outcomes?
Read the worked answer
Counseling: Explain that both options are surgical. AUS: Involves a cuff around the urethra, a pump in the scrotum, and a balloon reservoir. It is considered the gold standard for moderate to severe incontinence, with high success rates (80-90% dry or improved). Risks: mechanical failure (10-15% at 5 years), infection/erosion (5-10%), need for revision, and the need to manipulate the pump to void. It requires manual dexterity and cognitive ability. Male sling: A mesh sling placed under the urethra to provide compression. It is less invasive, does not require a pump, and has good results for mild incontinence (1-3 pads). Risks: transient perineal pain, urinary retention, infection, erosion, and failure (up to 20-30% may require further surgery). It is less effective for severe incontinence or low VLPP. In this patient with 3 pads/day and VLPP 60, AUS is likely more effective, but sling may be considered if he prefers a simpler procedure. Discuss that both require a catheter and hospital stay. Also mention that incontinence may improve up to 12-18 months post-prostatectomy, so he could continue conservative measures for another 6 months. Shared decision-making is essential.